MOLCURE Inc., (Kanagawa, Japan; CEO: Ryu Ogawa; “MOLCURE”) today announced that it has entered into a drug discovery collaboration agreement with Ono Pharmaceutical Co., Ltd. (Osaka, Japan; President and CEO: Gyo Sagara; “Ono”), to discover and develop innovative antibody drugs for multiple targets utilizing MOLCURE’s AI-driven platform technology. Under the terms of the agreement, MOCLURE will discover and identify antibodies or molecules for multiple targets of interest selected by Ono, using MOLCURE’s proprietary AI-driven platform technology. Ono will obtain option rights to exclusively and globally develop and commercialize therapeutic antibody drug candidates generated through the collaboration. Ono will pay to MOLCURE an upfront payment and research funding, and success-based milestone […]

株式会社MOLCURE（本社：神奈川県川崎市、代表取締役：小川 隆、以下「MOLCURE」）は、本日、小野薬品工業株式会社（本社：大阪市中央区、代表取締役社長：相良 暁、以下「小野薬品」）と、MOLCUREのAI創薬プラットフォーム技術を活用した複数の標的に対する革新的な抗体医薬品を創製することを目的とした創薬提携契約を締結しましたので、お知らせします。 詳細は以下のリンクをご覧ください。 Press release link:https://prtimes.jp/main/html/rd/p/000000007.000083912.html

MOLCURE today announced the appointment of leading biotechnology executive-scientist Dr. Han Lim, M.B.B.S., Ph.D. as strategic advisor. Dr. Lim is currently the Chief Business Officer at DeepCure, Inc., and was formerly the Chief Business Officer at Atomwise Inc. He has also served on a number of boards and steering committees, and is a frequent speaker and panelist on artificial intelligence (AI) enabled drug discovery. Dr. Lim has broad operational and management experience in growing AI biotechnology companies. He is an internationally recognized leader in business development, having formed AI drug discovery partnerships with pharmaceutical and biotechnology companies, launched joint venture companies, and established collaborative research projects with more than 500 […]

MOLCUREは、本日バイオテクノロジーのトップエグゼクティブであるDr. Han Lim, M.B.B.S., Ph.D.,を戦略アドバイザーとして任命したことを発表しました。 詳細は以下のリンクをご覧ください。 Press release link:https://prtimes.jp/main/html/rd/p/000000006.000083912.html